GLP-1 receptor agonists, such as Semaglutide and Ozempic, mimic the action of this hormone, leading to improved blood sugar control and other metabolic benefits
This guide breaks down the doses, what the scale actually moves to, side effects to expect, how it stacks up against Ozempic, Wegovy, and Mounjaro, and where it fits into a broader weight loss plan
Best Diet for Semaglutide in 2026 For the broader cluster context, see the semaglutide diet and food hub
To-date, we have data to support longevity for a few years and will continue to monitor how many years patients can expect to see the substantial improvement
I just eat food, go there, and be starving by the time I left, and then head home and go back again
Both medications are GLP-1 receptor agonists, but Zepbound also targets the GIP receptor, which may offer additional benefits for weight loss and blood sugar control compared to Semaglutide GLP-1